“Sonidegib Duration of Response in Advanced Basal Cell Carcinoma: Long-term Results from the Phase 2 BOLT Trial” (2018) SKIN The Journal of Cutaneous Medicine, 2(S1), p. S50. doi:10.25251/skin.2.supp.50.